224
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Thiostrepton inhibits growth and induces apoptosis by targeting FoxM1/SKP2/MTH1 axis in B-precursor acute lymphoblastic leukemia cells

, , , , & ORCID Icon
Pages 3170-3180 | Received 27 Apr 2021, Accepted 10 Jul 2021, Published online: 09 Aug 2021

References

  • Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339(9):605–615.
  • Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577.
  • Campos-Sanchez E, Toboso-Navasa A, Romero-Camarero I, et al. Acute lymphoblastic leukemia and developmental biology: a crucial interrelationship. Cell Cycle. 2011;10(20):3473–3486.
  • Wang Z, Ahmad A, Li Y, et al. Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat Rev. 2010;36(2):151–156.
  • Buchner M, Park E, Geng H, et al. Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia. Nat Commun. 2015;6:6471.
  • Gu C, Yang Y, Sompallae R, et al. FOXM1 is a therapeutic target for high-risk multiple myeloma. Leukemia. 2016;30(4):873–882.
  • Nakamura S, Hirano I, Okinaka K, et al. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. Carcinogenesis. 2010;31(11):2012–2021.
  • Khan I, Halasi M, Zia MF, et al. Nuclear FOXM1 drives chemoresistance in AML. Leukemia. 2017;31(1):251–255.
  • Uddin S, Ahmed M, Hussain A, et al. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy. Am J Pathol. 2011;178(2):537–547.
  • Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci. 2006;11:1696–1701.
  • Hynes-Smith RW, Wittorf KJ, Buckley SM. Regulation of normal and malignant hematopoiesis by FBOX Ubiquitin E3 Ligases. Trends Immunol. 2020;41(12):1128–1140.
  • Kulinski M, Achkar IW, Haris M, et al. Dysregulated expression of SKP2 and its role in hematological malignancies. Leuk Lymphoma. 2018;59(5):1051–1063.
  • Krishnan A, K D, Babu PSS, et al. Oncogenic actions of SKP2 involves deregulation of CDK1 turnover mediated by FOXM1. J Cell Biochem. 2017;118(4):797–807.
  • Wang IC, Chen YJ, Hughes D, et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol. 2005;25(24):10875–10894.
  • Rai P, Sobol RW. Mechanisms of MTH1 inhibition-induced DNA strand breaks: the slippery slope from the oxidized nucleotide pool to genotoxic damage. DNA Repair. 2019;77:18–26.
  • Wang JY, Liu GZ, Wilmott JS, et al. Skp2-mediated stabilization of MTH1 promotes survival of melanoma cells upon oxidative stress. Cancer Res. 2017;77(22):6226–6239.
  • Bhat UG, Halasi M, Gartel AL. FoxM1 is a general target for proteasome inhibitors. PLoS One. 2009;4(8):e6593.
  • Radhakrishnan SK, Bhat UG, Hughes DE, et al. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1. Cancer Res. 2006;66(19):9731–9735.
  • Nicolaou KC, Zak M, Rahimipour S, et al. Discovery of a biologically active thiostrepton fragment. J Am Chem Soc. 2005;127(43):15042–15044.
  • Bruckner L, Reinshagen A, Hoang NA, et al. FOXM1 inhibition in Ovarian cancer tissue cultures affects individual treatment susceptibility ex vivo. Cancers. 2021;13(5):956.
  • Ahmed M, Hussain AR, Siraj AK, et al. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells. Mol Cancer. 2015;14:131.
  • Consolaro F, Basso G, Ghaem-Magami S, et al. FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugs. Int J Oncol. 2015;47(4):1230–1240.
  • Kuttikrishnan S, Siveen KS, Prabhu KS, et al. Sanguinarine suppresses growth and induces apoptosis in childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2019;60(3):782–794.
  • Prabhu KS, Siveen KS, Kuttikrishnan S, et al. Greensporone C, a freshwater fungal secondary metabolite induces mitochondrial-mediated apoptotic cell death in leukemic cell lines. Front Pharmacol. 2018;9:720.
  • Shishodia S, Sethi G, Ahn KS, et al. Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem Pharmacol. 2007;74(1):118–130.
  • Khan AQ, Mohamed EAN, Hakeem I, et al. Sanguinarine induces apoptosis in papillary thyroid cancer cells via generation of reactive oxygen species. Molecules. 2020;25(5):1229.
  • Oh H, Yoon G, Shin JC, et al. Licochalcone B induces apoptosis of human oral squamous cell carcinoma through the extrinsic- and intrinsic-signaling pathways. Int J Oncol. 2016;48(4):1749–1757.
  • Kuttikrishnan S, Siveen KS, Prabhu KS, et al. Curcumin induces apoptotic cell death via inhibition of PI3-Kinase/AKT pathway in B-precursor acute lymphoblastic leukemia. Front Oncol. 2019;9:484.
  • Nunez G, Benedict MA, Hu Y, et al. Caspases: the proteases of the apoptotic pathway. Oncogene. 1998;17(25):3237–3245.
  • Lalaoui N, Vaux DL. Recent advances in understanding inhibitor of apoptosis proteins. F1000Res. 2018;7:1889.
  • Hussain AR, Al-Jomah NA, Siraj AK, et al. Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Res. 2007;67(8):3888–3897.
  • Kerksick C, Willoughby D. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr. 2005;2:38–44.
  • Uddin S, Hussain AR, Ahmed M, et al. Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma. Haematologica. 2012;97(7):1092–1100.
  • Ahmed M, Uddin S, Hussain AR, et al. FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2012;97(1):E1–E13.
  • Gu C, Holman C, Sompallae R, et al. Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome. Blood Cancer J. 2018;8:22.
  • Hussain AR, Al-Rasheed M, Manogaran PS, et al. Curcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in acute T cell leukemias. Apoptosis. 2006;11(2):245–254.
  • Hussain AR, Ahmed M, Al-Jomah NA, et al. Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol Cancer Ther. 2008;7(10):3318–3329.
  • Littlepage LE, Sternlicht MD, Rougier N, et al. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res. 2010;70(6):2224–2234.
  • Rodriguez S, Abundis C, Boccalatte F, et al. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL. Leukemia. 2020;34(5):1241–1252.
  • Zeng J, Wang L, Li Q, et al. FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1. J Pathol. 2009;218(4):419–427.
  • Grigor'ev Iu G, Luk'ianova SN, Makarov VP, et al. The dynamic analysis of the functional status of a test subject after 1.5-hour monotonous operator activity. Fiziol Cheloveka. 1990;16:158–161.
  • Mazurkiewicz M, Hillert EK, Wang X, et al. Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition. Oncotarget. 2017;8(13):21115–21127.
  • Uddin S, Bhat AA, Krishnankutty R, Mir F, et al. Involvement of F-BOX proteins in progression and development of human malignancies. Semin Cancer Biol. 2016;36:18–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.